IP44-02: Validation of the Cambridge, EAU, and STARCAP Prognostic Score in Predicting Biochemical Recurrence in Contemporary Prostate Cancer Patients Treated with Radical Prostatectomy in the MRI Era

IP44-02: Validation of the Cambridge, EAU, and STARCAP Prognostic Score in Predicting Biochemical Recurrence in Contemporary Prostate Cancer Patients Treated with Radical Prostatectomy in the MRI Era

Saturday, May 16, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
146A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!